Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines

Autor: Ma, Tempero, Jp, Arnoletti, Sw, Behrman, Ben-Josef E, Ab, Benson Rd, Es, Casper, Sj, Cohen, Czito B, Jd, Ellenhorn, Wg, Hawkins, Herman J, Jp, Hoffman, Ko A, Srinadh Komanduri, Koong A, Ww, Ma, Mp, Malafa, Nb, Merchant, Sj, Mulvihill, Nd, Muscarella P., Ek, Nakakura, Obando J, Mb, Pitman, Ar, Sasson, Tally A, Sp, Thayer, Whiting S, Ra, Wolff, Bm, Wolpin, Da, Freedman-Cass, Da, Shead, National Comprehensive Cancer Networks

Publikováno v: Europe PubMed Central
Journal of the National Comprehensive Cancer Network : JNCCN, vol 10, iss 6

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma discuss the workup and management of tumors of the exocrine pancreas. These NCCN Guidelines Insights provide a summary and explanation of major changes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::99b0e16e0eaa2852997bf76d2119672e
http://europepmc.org/abstract/med/22679115

General Anesthetics in CAncer REsection Surgery (GA-CARES) randomized multicenter trial of propofol vs volatile inhalational anesthesia: protocol description.

Autor: Bennett-Guerrero E; Department of Anesthesiology, Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA. Elliott.Bennett-Guerrero@StonyBrookMedicine.edu., Romeiser JL; Department of Anesthesiology, Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA., DeMaria S; Department of Anesthesiology, Perioperative and Pain Medicine, The Icahn School of Medicine at Mount Sinai, New York, NY, USA., Nadler JW; Department of Anesthesiology and Perioperative Medicine, University of Rochester School of Medicine, New York, NY, USA., Quinn TD; Department of Anesthesiology, Preoperative Medicine and Pain Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ponnappan SK; Department of Anesthesiology, Long Island Jewish Medical Center at Northwell Health, New Hyde Park, NY, USA., Yang J; Department of Family, Population and Preventive Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA., Sasson AR; Department of Surgery/Surgical Oncology, Renaissance School of Medicine at Stony, Brook University, Stony Brook, NY, USA.

Publikováno v: Perioperative medicine (London, England) [Perioper Med (Lond)] 2023 Jan 11; Vol. 12 (1), pp. 2. Date of Electronic Publication: 2023 Jan 11.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.

Autor: Fishbein L; From the Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Del Rivero J; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Else T; Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI., Howe JR; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA., Asa SL; Department of Pathology, University Hospitals Cleveland Medical Center and University Health Network, Toronto, Case Western Reserve University, Cleveland, OH., Cohen DL; Renal Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Dahia PLM; Division of Hematology and Medical Oncology, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX., Fraker DL; Division of Endocrine and Oncologic Surgery, Department of Surgery, University of Pennsylvania and Abramson Cancer Center, Philadelphia, PA., Goodman KA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA., Kunz PL; Division of Oncology, Department of Medicine, Yale School of Medicine, New Haven, CT., Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Perrier ND; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Pryma DA; Department of Radiology and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Ryder M; Endocrine Oncology Tumor Group, Division of Medical Oncology, Mayo Clinic, Rochester, MN., Sasson AR; Division of Surgical Oncology, Department of Surgery, Stony Brook University Medical Center, Stony Brook, NY., Soulen MC; Department of Radiology, University of Pennsylvania, Philadelphia, PA., Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publikováno v: Pancreas [Pancreas] 2021 Apr 01; Vol. 50 (4), pp. 469-493.

Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.

Autor: Gao M; Department of Surgery, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Lin M; Department of Surgery, University of Kentucky, Lexington, KY, USA., Moffitt RA; Department of Pathology, State University of New York, Stony Brook, NY, USA., Salazar MA; Department of Experimental Therapeutics, City of Hope, Duarte, CA, USA., Park J; Department of Radiology, University of Iowa, Iowa City, IA, USA., Vacirca J; New York Cancer Specialists, East Setauket, New York, NY, USA., Huang C; Departments of Radiology, State University of New York, Stony Brook, NY, USA.; Departments of Psychiatry, State University of New York, Stony Brook, NY, USA., Shroyer KR; Department of Pathology, State University of New York, Stony Brook, NY, USA., Choi M; Departments of Medicine, State University of New York, Stony Brook, NY, USA., Georgakis GV; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Sasson AR; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Talamini MA; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Kim J; Department of Surgery, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.

Publikováno v: British journal of cancer [Br J Cancer] 2020 Aug; Vol. 123 (3), pp. 495.

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer.

Autor: Gao M; Department of Surgery, University of Kentucky, Lexington, KY, USA.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA., Lin M; Department of Surgery, University of Kentucky, Lexington, KY, USA., Moffitt RA; Department of Pathology, State University of New York, Stony Brook, NY, USA., Salazar MA; Department of Experimental Therapeutics, City of Hope, Duarte, CA, USA., Park J; Department of Radiology, University of Iowa, Iowa City, IA, USA., Vacirca J; New York Cancer Specialists, East Setauket, New York, NY, USA., Huang C; Departments of Radiology, State University of New York, Stony Brook, NY, USA.; Departments of Psychiatry, State University of New York, Stony Brook, NY, USA., Shroyer KR; Department of Pathology, State University of New York, Stony Brook, NY, USA., Choi M; Departments of Medicine, State University of New York, Stony Brook, NY, USA., Georgakis GV; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Sasson AR; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Talamini MA; Departments of Surgery, State University of New York, Stony Brook, NY, USA., Kim J; Department of Surgery, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.; Markey Cancer Center, University of Kentucky, Lexington, KY, USA. joekim7@yahoo.com.

Publikováno v: British journal of cancer [Br J Cancer] 2019 Jan; Vol. 120 (1), pp. 88-96. Date of Electronic Publication: 2018 Oct 31.